Fran Priddy | Executive Director, Clinical Development
Moderna

Fran Priddy is Executive Director of Clinical Development at Moderna, where she leads clinical development programs for mRNA vaccines targeting infectious diseases, including latent, bacterial, and global public health pathogens. She has more than 20 years of experience in vaccine and clinical development across the biotechnology and global health sectors. Her work has focused on the design and implementation of clinical development strategies for novel vaccines, spanning early- through late-stage development. Her interests include clinical trial design, global partnerships and capacity building, and development of vaccines for diseases of public health importance. At the World Vaccine Congress Europe 2026, she will discuss the clinical development of Moderna’s novel vaccine against Bundibugyo ebolavirus.